Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.45 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 4/20 | 0.40 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.40 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.39 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.39 |
| ▸ | IGLV6-57 | P01721 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7255639 | 1.00 | TAAR1 (0.45) | TAAR1AOC3TRPA1RIPK1GRIA4 | |
| SCHEMBL7259968 | 1.00 | TAAR1 (0.45) | TAAR1AOC3TRPA1RIPK1GRIA4 | |
| SCHEMBL7516303 | 0.84 | CA12 (0.46) | TAAR1 | |
| SCHEMBL11041736 | 0.83 | GRIA4 (0.45) | GRIA4 | |
| SCHEMBL14441665 | 0.83 | CA1 (0.50) | TAAR1AOC3PTGES2 | |
| SCHEMBL5878353 | 0.81 | PLCG1 (0.38) | GRIA4 | |
| SCHEMBL5877993 | 0.81 | PLCG1 (0.38) | GRIA4 | |
| SCHEMBL18359541 | 0.81 | PTGES2 (0.40) | GRIA4PTGES2 | |
| SCHEMBL11958126 | 0.81 | CA1 (0.39) | GRIA4 | |
| SCHEMBL10472662 | 0.81 | RIPK1 (0.46) | TAAR1AOC3TRPA1RIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003070239-A1 | BENZYLIDENE THIAZOLIDINEDIONES AND THEIR USE AS ANTIMYCOTIC AGENTS | OXFORD GLYCOSCIENCES (UK) LTD (GB) | 2003-08-28 | — | — | WO | disclosed |
| WO-2003070238-A1 | THIAZOLIDINE ANTIFUNGAL AGENTS | OXFORD GLYCOSCIENCES (UK) LTD (GB) | 2003-08-28 | — | — | WO | disclosed |